NanoViricides Inc. (NNVC)

[NNVClover]

By then Atripla will be generic and one pill, once-a-day will cost <$1 a day. HIV is just not an interesting market, sorry.

Dengue is a shot in the dark that everyone is taking. This company has nothing interesting.

You should have learned more about HIV before committing to this. There are twenty drugs approved. The only area of unmet need is Africa, and that is a societal thing - they just don't like taking medicines and complying with them - education will have to take place over decades and centuries. There is no market for a new HIV drug unless it is targeting patients who are non-compliant with their combination drugs or people who were infected 10-20 years ago. For those patients the generic market is available as doctors swap out NRTIs for different NRTIs. There is endless swapping. New integrase inhibitors are doing well, however. So maybe there is hope.